Releases

Find the latest information about Alpha MOS company

2024 Releases

25/04/2024: FY 2023 Results

05/04/2024: BOYDSENSE completes a 7m€ capital increase to further develop its non-invasive glucose monitoring device

 

2023-2022 Releases

30/10/2023: Interim results at June 30, 2023

01/06/2023: Conclusion of the 2nd BOYDSense clinical study

11/05/2023: Mengniu, a Chinese leader of dairy products validates Alpha MOS electronic noses performance for milk control

07/02/2023: BOYDSense (an Alpha MOS subsidiary), selected among the 12 most innovative French Medtech by the National Union of the Medical Technology Industry (SNITEM)

12/12/2022: BOYDSense awarded by the DCB Innovation Challenge 2022 Expert Jury

30/08/2022: Development acceleration booster for BOYDSense’s breath analyser platform for people living with Diabetes thanks to the support of the European Innovation Council (EIC)

03/02/2022: Ben Delhey appointed as CEO of BOYDSense, the MedTech subsidiary of Alpha MOS

18/01/2022: Alpha MOS announces the appointment of three Senior Advisors to its Executive Board

 

Previous releases

Archives